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Purpose: The traditional measure of success after exclusion and bypass of popliteal artery aneurysm (PAA) is graft patency.
In addition to fate of the bypass, we hypothesize that late outcome after surgical treatment of PAA is influenced by
completeness of exclusion.
Methods: Thirty patients who underwent 41 reconstructions for PAA over a 10-year period were reviewed.
Results: Excluded PAAs were examined with duplex ultrasound scan for size, patency, and patent feeding branches; bypass
grafts and native inflow and outflow arteries were examined for patency and size. Thirty-six limbs were available for
follow-up (mean follow-up period, 46 42 months). Only two aneurysms (5.6%) appeared patent on duplex ultrasound
scan, but five limbs had patent arterial branches communicating with thrombosed excluded PAAs. PAA diameter
decreased from 2.5 0.8 cm to 1.7 0.5 cm (P < .0001) in most. However, 12 excluded PAAs (33%) showed significant
enlargement from 2.2  0.9 cm to 2.8  1.0 cm (P  .002). A quarter of enlarging excluded PAA were associated with
new compressive symptoms. Three methods of PAA exclusion were used: proximal and distal ligation with short segment
isolation (type 1), proximal and distal ligation with long segment isolation (type 2), and single ligature (type 3). In
univariate analysis, type of exclusion significantly influenced late size of excluded PAA (P  .004). Type 1 exclusion was
superior to both type 2 and 3 exclusions in producing aneurysm diameter reduction. Type 3 exclusion resulted in
aneurysm growth. In addition, excluded aneurysms with visualized feeding branches were associated with significant
growth compared with PAAs without feeding branches (P  .006). Graft primary and assisted primary patency rates at
5 years were 86%  9.4% and 92%  7.4%, respectively. Although graft diameter and native donor artery diameter
significantly increased, this did not adversely affect graft patency.
Conclusion: Enlargement of excluded PAA after surgical treatment can cause compressive symptoms. Exclusion requires
adequate vascular isolation to prevent late PAA enlargement, with proximal and distal arterial ligation best performed
adjacent to the aneurysm. Vein graft enlargement occurs, but this enlargement does not adversely influence patency. (J
Vasc Surg 2003;37:392-8.)
The goals of surgical treatment of popliteal artery an-
eurysm (PAA) are isolation of the aneurysm preventing
distal embolization and effective revascularization after ex-
clusion. Previous studies have measured success of surgical
treatment with well-established criteria for graft patency
and limb salvage.1-4 Outcomes have been generally favor-
able despite the typical compromised tibial and pedal runoff
from silent, subacute, or acute atheroembolism from the
popliteal artery.5-7 Several methods of excluding the PAA
have been described.8,9 No study has been performed that
evaluated the influence of the type of exclusion or the
completeness of exclusion on late outcome after surgical
treatment. We hypothesize that late outcome of bypass and
exclusion of PAA is influenced by the completeness of
exclusion.
METHODS
All patients who underwent repair of popliteal aneu-
rysms from 1991 to 2001 were identified from our vascular
registry. Patient demographics were derived from patient
records. Preoperative indications, including presenting
symptoms and aneurysm size, were recorded. With surgical
operative reports and diagrams, method of repair, including
donor and recipient artery for bypass, and method of aneu-
rysm exclusion were noted. Three methods of PAA exclu-
sion were used: proximal and distal aneurysm ligation with
short segment isolation (type 1; Fig 1), proximal and distal
ligation with long segment isolation (type 2; Fig 2), and
single ligature alone (type 3; Fig 3).
All patients were enrolled in a graft surveillance proto-
col that included evaluation of graft patency and PAA size
and patency. Initial studies were performed within 6 weeks
of surgical repair. Inflow and outflow vessel diameters were
measured with calipers according to the technique de-
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scribed by Upchurch et al.4 Initial graft diameter was
measured at the mid portion of the bypass. Native artery
diameters were measured proximal to the proximal anasto-
mosis for inflow vessel and distal to the distal anastomosis
for outflow vessel.
Patients were reevaluated at last follow-up with duplex
ultrasound scan (HDI 5000, ATL, Bothel, Wash). Native
artery and bypass graft diameters were remeasured with the
caliper method and with ultrasonic calipers when available.
Excluded PAAs were evaluated for patency, visible feeding
arterial branches, and maximal transverse diameter.
Initial and late arterial, graft, and PAA diameter were
compared with a paired t test. Analysis of variance univari-
ate analysis was performed to examine the influence of
method of exclusion, PAA patency, and presence or ab-
sence of patent feeding arterial branches on growth of
excluded aneurysms or graft patency. Relationships be-
tween continuous variables were examined with linear re-
gression.
RESULTS
Demographics. Thirty patients (29 male, one female)
underwent 41 reconstructions for PAA over the study
period. The mean age of our cohort was 76  8.7 years.
Typical comorbid medical conditions included: hyperten-
sion (60%), diabetes mellitus (16%), hyperlipidemia (43%),
and coronary artery disease (30%). Eleven subjects (36%)
were current heavy tobacco users. Twelve patients (40%)
had bilateral PAA, and 80% (n  24) were found to have
coexisting abdominal aortic aneurysms.
Procedures. All patients underwent preoperative du-
plex ultrasound scan assessment of their aneurysms. Preop-
erative arteriography was performed on 25 patients, two
Fig 1. Type I exclusion: Proximal and distal ligation with short
segment isolation.
Fig 2. Type II exclusion: Proximal and distal ligation with long
segment isolation.
Fig 3. Type III exclusion: Single ligature ligation.
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patients had preoperative magnetic resonance imaging
scans, and two patients had preoperative computed tomo-
graphic scans. Bypass and exclusion of the aneurysm was
the preferred method of repair. All patients had their aneu-
rysms repaired through a medial approach. No patients
underwent direct endoaneurysmorrhapy or aneurysm exci-
sion. Most procedures were performed electively, with only
9% (n  4) requiring emergency procedures for acute
limb-threatening ischemia (n 3) or rupture (n 1). Four
patients (9%) underwent repair for symptoms related to
compression of adjacent structure, including three patients
with coexisting acute popliteal deep venous thromboses.
Reversed greater saphenous vein was the conduit of choice
in all but two patients. Both of these patients lacked suitable
lower extremity saphenous vein. One required spliced up-
per extremity vein for bypass, and the other required bilat-
eral reconstructions with prosthetic conduit.
Inflow arteries varied considerably among the 41 re-
constructions. The common femoral artery was used in 11
cases (27%). The proximal superficial femoral artery pro-
vided inflow in seven cases (17%). The distal superficial
femoral artery was used in 11 reconstructions (27%).
Eleven bypasses (27%) used the above-knee popliteal artery
as a donor vessel. The remaining bypass originated from the
deep femoral artery. The infrageniculate popliteal artery
served as the outflow artery in most cases. Only five by-
passes (12%) required an infrapopliteal distal anastomosis
to a tibial artery.
Method of PAA exclusion was clearly documented for
38 procedures. Adequate documentation of exclusion type
was missing in three procedures. Type 1 exclusions were
used in 53% of limbs (n  20). Size of aneurysms treated
with this method ranged from 1.5 cm to 4.1 cm (average,
2.67 cm). Ten PAAs (26%) were excluded with type 2
arterial ligation. Size of aneurysms ranged from 1.4 cm to
4.5 cm (average, 2.46 cm). The single ligature method
(type 3) was used to exclude eight PAAs (21%). Size of
aneurysms treated ranged from 1.5 cm to 4.5 cm (average,
2.28 cm).
Follow-up. The mean follow-up period was 46  42
months (range, 11 to 123 months). Of the 41 limbs, two
patients lost their limbs within the first 2 months after
bypass because of extensive wound complications and three
patients were lost to follow-up, leaving 36 limbs available
for late duplex scan evaluation of the excluded PAA. Most
aneurysms were occluded on follow-up. Only two of 36
PAAs (5.6%) remained patent. However, five limbs (13.8%)
had patent arterial branches in direct communication with
apparently thrombosed, excluded PAAs (Fig 4). Overall,
the mean maximal diameter of the excluded PAA decreased
from 2.4  0.8 cm to 2.0  0.9 cm (P  .02; Fig 5). Two
thirds of the excluded aneurysms (n  24) decreased from
2.5  0.8 cm to 1.7  0.5 cm (P  .0001). However, a
significant third of aneurysms (n 12) were found to have
enlarged considerably in the follow-up period, from 2.2 
0.9 cm to 2.8  1.0 cm (P  .002). A quarter of these
enlarging aneurysms were associated with new compressive
symptoms. Two patients had a more than 50% diameter
increase, one from 3 cm to 4.5 cm in diameter and the other
from 2.2 cm to 3.3 cm in diameter. New symptoms usually
consisted of local pain and tenderness and occurred in
patients whose aneurysms had increased 25% to 50% in
diameter.
In univariate analysis, the method of PAA exclusion
significantly influenced the late size of excluded PAA (P 
.004). Type 1 (short segment isolation) was independently
superior to both type 2 (long segment isolation) and type 3
(single ligature) exclusions in producing aneurysm diame-
Fig 4. Ultrasound scan of popliteal aneurysm with patent arterial feeding vessels.
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ter reduction (Fig 6). The short segment isolation (type 1)
resulted in an average 0.8-cm diameter reduction. Long
segment isolation (type 2) of the intervening arterial seg-
ment did not consistently result in aneurysm shrinkage, but
it was not associated with aneurysm growth. The single
ligature (type 3) method of exclusion resulted in aneurysm
enlargement.
Similarly, the presence or absence of visible arterial
branches feeding the excluded aneurysm sac on duplex scan
significantly influenced final aneurysm size (P  .006; Fig
7). The five aneurysms with visible patent aneurysm
branches had grown an average of 0.6 cm on final measure-
ment. Aneurysms without visible feeding arterial branches
decreased by an average 0.5 cm in diameter.
Native arterial inflow vessels and vein graft themselves
showed significant increase in diameter on late follow-up.
Inflow vessels significantly increased in diameter from
0.9 0.3 cm to 1.1 0.3 cm (P .01). Similarly, midgraft
diameters increased from 0.7  0.1 cm to 0.8  0.1 cm
(P .003). Focal short segment graft aneurysms developed
in three limbs (7.9%). These focal aneurysms (mean diam-
eter, 1.4  0.1 cm) were uniformly located in the distal
Fig 5. Overall aneurysm size change.
Fig 6. Aneurysm size change in reference to method of exclusion.
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third of the bypass grafts. On linear regression, no predict-
able correlation was seen between native arterial size and
graft diameter. Outflow vessels did not show significant
diameter change during the follow-up period. Final PAA
diameter was not influenced by native arterial or vein graft
enlargement. Graft primary and assisted primary patency
rates at 5 years were 86%  9.4% and 92%  7.4%, respec-
tively (Figs 8 and 9, online only). Changing aneurysm,
graft, or native artery diameters did not adversely affect
graft patency. The limb salvage rate at 2 years was 89%.
DISCUSSION
Successful elective repair of PAA requires fulfillment of
a single important goal: prevention of limb loss from cata-
strophic thrombosis or from atheroembolism. The clarity
of this goal has prompted most vascular surgeons to per-
form prophylactic repair of asymptomatic larger
PAAs.1,2,10 Methods of repair vary, ranging from direct
endoaneurysmorrhapy to bypass and exclusion of the PAA.
The choice of repair is largely dictated by anatomy of the
aneurysm and the extent of coexisting occlusive disease.
Despite these variables, bypass and exclusion of the aneu-
rysm remains the most frequently used method of surgical
treatment.1-3,5,6,11 Such an operative approach is designed
to reduce injury to structures adherent to the PAA, such as
the vein or tibial nerve. Exclusion can be achieved with
several methods, all anatomically isolating the distal tibial
and pedal arterial circulation from the PAA. We have typi-
cally used three methods of exclusion. Type 1 exclusion is
achieved by applying ligatures just proximal and distal to
the PAA, removing the aneurysm from axial arterial blood
flow. This technique is typically used with a focal aneurysm
and a superficial femoral artery free from significant occlu-
sive disease. This allows placement of a shorter bypass that
draws inflow from the distal superficial femoral artery or the
above-knee popliteal artery. The resulting isolated popliteal
artery segment is relatively short. Type 2 exclusion is ac-
complished with isolating a longer segment of artery. More
extensive fusiform aneurysms combined with significant
femoral-popliteal occlusive disease usually necessitate
placement of the proximal graft anastomosis at the com-
mon femoral artery. The ligatures are placed just distal to
the femoral bifurcation at the proximal superficial femoral
artery and distal to the PAA. The final method (type 3) of
exclusion merely prevents distal embolization from the
PAA. A single ligature is placed distal to the PAA.
With traditional measures of success, our patients faired
well. Our 5-year graft patency and revision rates were
typical when compared with other series of PAA repairs.1-
5,7 Overall, the PAA exclusions resulted in aneurysm
thrombosis and reduction in size. However, a significant
third of patients had actual aneurysm enlargement on fol-
low-up, several with an up to 50% increase in size. This is
not a new or innocuous phenomenon. In a series of 51
surgically treated popliteal aneurysms, Shortell and col-
leagues3 reported four patients in whom massive recurrent
popliteal aneurysms in excess of 5 cm developed in previ-
ously isolated segments. All had significant symptoms re-
lated to local compression and were excised. In their series,
all antecedent procedures were bypasses and exclusions.
Flynn and Nicholas12 also reported two patients with late
and symptomatic enlargement despite previous ligation. In
our experience, a quarter of patients with late PAA enlarge-
ment also had new symptoms develop related to compres-
Fig 7. Graph of aneurysm growth from patent feeding vessels.
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sion of adjacent structures. After examining our patients,
two apparent anatomic conditions appeared to contribute
to continued aneurysm enlargement: method of exclusion
and visible patent arterial branches feeding the excluded
aneurysm.
Type 3 exclusions only failed to result in aneurysm
shrinking. PAA treated with type 3 exclusions continued to
significantly grow. Type 1 exclusion was clearly associated
with significant aneurysm diameter reduction. Type 2 ex-
clusion was not associated with size reduction but did not
result in PAA enlargement. Therefore, type 1 and 2 exclu-
sions appear to be more effective at isolating the PAA. This
is not unexpected because type 3 reconstructions are per-
formed with only a single ligature. The PAA is isolated from
the distal circulation but not from direct axial inflow.
Notably, the two PAAs that were not thrombosed on
ultrasound scan had undergone type 3 exclusions, attesting
to the inferiority of this technique in truly isolating the
aneurysm.
Incomplete axial exclusion was not the only factor
contributing to aneurysm enlargement. We noted a num-
ber of patients with patent arterial branches visible on color
flow duplex ultrasound scan leading to occluded aneurysm
sacs. The presence of patent branches was associated with
late aneurysm enlargement. They were found in all types of
exclusions. Enlargement occurred despite an apparent lack
of detectable flow in the excluded aneurysm sacs. Shortell et
al3 also observed excluded aneurysm enlargement in aneu-
rysms with surgically confirmed complete thrombosis. Al-
though they failed to note any feeding branches in these
patients, they speculated on the presence of small collaterals
imparting near systemic pressures to excluded aneurysms.
Darling and colleagues13 described an arguably analogous
anatomic situation involving excluded abdominal aortic
aneurysms. Aortic aneurysms treated with bypass and axial
exclusion enlarged or ruptured despite removal from major
inflow and outflow. Persistent feeding vessels and aneurysm
flow were visualized in many but not all patients. The ability
of collateral vessels to produce systemic levels of arterial
pressure and subsequent rupture in excluded aneurysms has
been described in an excluded PAA in a case report by
Battey, Skardasis, and McKinnon.14 This previously ex-
cluded ruptured PAA was explored and opened; a large
back-bleeding arterial collateral was found just proximal to
the site of distal ligation allowing retrograde filling of the
aneurysm sac. Persistent collaterals may also explain differ-
ences noted between type 1 and 2 exclusions seen in our
study. Type 2 exclusions did not result in consistent PAA
diameter reduction. Remaining segments of superficial
femoral artery are necessarily longer in type 2 exclusions.
These longer segments, though often diseased, may pro-
vide many more branches in direct communication with the
excluded aneurysm. In addition, because type 2 exclusions
are often performed in patients with concomitant femoral-
popliteal occlusive disease, more extensive collaterals may
be present when compared with type 1 candidates. How-
ever, this remains only speculation.
Observations regarding late changes in graft diameter
were not as dramatic as those observed in the excluded
aneurysms. In their series of vein grafts placed for treatment
of PAA, Upchurch and associates4 observed a similar graft
enlargement over time. They speculated that this remodel-
ing might contribute to more durable graft patency in
patients treated for PAA compared with those treated for
occlusive disease. In our cohort, vein grafts and inflow
arteries enlarged a small but significant amount during the
study period. However, final graft patency did not appear
to be influenced by changes in graft diameter.
The limitations of this study are relatively clear. The
retrospective nature of the study and the small cohort of
patients are significant drawbacks. The heterogeneity in
types of procedures leads to imposition of a somewhat
arbitrary classification scheme. Classification of a particular
procedure within one category or another (particularly type
1 or 2 repairs) was largely subjective. However, in actual
practice, the chosen classifications have real and distinctive
applicability to specific clinical scenarios. The dramatic
nature of the late changes in PAA size and the strong
association with the method of exclusion and patent feed-
ing vessels stress the importance of planning and executing
as complete an exclusion of the popliteal aneurysm possi-
ble. Although methods of exclusion involving a single
ligature may be effective at preventing future thromboem-
bolism to the distal arterial circulation, they do not result in
arrest of aneurysm growth. Because local compression from
enlarging partially excluded aneurysms is a true clinical
entity, we believe that type 3 exclusions should be aban-
doned. Similarly, to provide late PAA diameter reduction,
proximal and distal ligatures should be placed as close to the
aneurysm as possible to reduce the length of the isolated
segment. In some cases, this may require additional dissec-
tion of the above-knee popliteal segment to facilitate prox-
imal ligation in patients requiring longer grafts.
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Table I, online only.
Interval
(mo)
Grafts at risk
at start
No. of failed
grafts
No. withdrawn patent
Interval
patency rate
Cumulative
patency (%)
Standard
error (%)Duration
Loss to
follow-up Death
0 0-1 42 0 0 0 1 1.00 100 0.0
3 1-3 41 1 2 1 0 0.97 100 0.0
6 3-6 37 2 0 0 0 0.95 97 2.5
9 6-9 35 0 0 0 0 1.00 92 4.4
12 9-12 35 0 2 2 0 1.00 92 4.4
15 12-15 31 2 1 4 0 0.93 92 4.6
18 15-18 24 0 1 0 0 1.00 86 6.6
21 18-21 23 0 1 1 0 1.00 86 6.8
24 21-24 21 0 3 0 0 1.00 86 7.1
27 24-27 18 0 0 0 0 1.00 86 7.6
30 27-30 18 0 0 0 0 1.00 86 7.6
33 30-33 18 0 0 0 0 1.00 86 7.6
36 33-36 18 0 0 2 0 1.00 86 7.6
39 36-39 16 0 0 1 0 1.00 86 8.1
42 39-42 15 0 0 0 0 1.00 86 8.4
45 42-45 15 0 0 0 0 1.00 86 8.4
48 45-48 15 0 1 0 0 1.00 86 8.4
51 48-51 14 0 0 0 0 1.00 86 8.7
54 51-54 14 0 0 0 0 1.00 86 8.7
57 54-57 14 0 1 0 0 1.00 86 8.7
60 57-60 13 0 1 0 0 1.00 86 9.0
63 60-63 12 0 0 0 0 1.00 86 9.3
Fig 8, online only. Graft primary patency and primary patency source date.
Table II, online only.
Interval
(mo)
Grafts at risk
at start
No. of failed
grafts
No. withdrawn patent
Interval
patency rate
Cumulative
patency (%)
Standard
error (%)Duration
Loss to
follow-up Death
0 0-1 42 0 0 0 1 1.00 100 0.0
3 1-3 41 1 2 1 0 0.97 100 0.0
6 3-6 37 2 0 0 0 0.95 97 2.5
9 6-9 35 0 0 0 0 1.00 92 4.4
12 9-12 35 0 2 2 0 1.00 92 4.4
15 12-15 31 0 1 4 0 1.00 92 4.6
18 15-18 26 0 1 0 0 1.00 92 5.1
21 18-21 25 0 1 1 0 1.00 92 5.2
24 21-24 23 0 3 0 0 1.00 92 5.4
27 24-27 20 0 0 0 0 1.00 92 5.8
30 27-30 20 0 0 0 0 1.00 92 5.8
33 30-33 20 0 0 0 0 1.00 92 5.8
36 33-36 20 0 0 3 0 1.00 92 5.8
39 36-39 17 0 0 1 0 1.00 92 6.2
42 39-42 16 0 0 0 0 1.00 92 6.4
45 42-45 16 0 0 0 0 1.00 92 6.4
48 45-48 16 0 1 0 0 1.00 92 6.4
51 48-51 15 0 0 0 0 1.00 92 6.6
54 51-54 15 0 0 1 0 1.00 92 6.6
57 54-57 14 0 1 0 0 1.00 92 6.9
60 57-60 13 0 1 0 0 1.00 92 7.1
63 60-63 12 0 0 0 0 1.00 92 7.4
Fig 9, online only. Graft primary assisted patency and primary assisted patency source data.
